drugset / Trial / NCT00891527

Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis

NCT00891527

Phase 1/2 Completed 50 enrolled Boston Children's Hospital
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to conduct a pilot study using biologic agents Avastin and Gleevec to treat progression of multivessel intraluminal pulmonary vein stenosis in children.

Timeline

Start
2008-10
Primary completion
2015-12
Completion
2015-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bevacizumab Monoclonal antibody 10 mg/kg Intravenous
Subject Imatinib Small molecule 340 mg/m2